Bristol Myers Squibb (NYSE: BMY) has posted better-than-expected second-quarter 2025 results, driven by strong sales of its ...

Shares of Spanish plasma-derived medicines specialist Grifols rose 9% yesterday after it announced results for the first half ...

Endometriosis remains a complex challenge for patients and drug developers, with GlobalData highlighting five major gaps ...

The US Food and Drug Administration has set prescription drug user fee rates for fiscal year 2026, with increases across all ...

Shares of US pharma major AbbVie were up 6.1% at $200.96 in pre-market activity, as it announced second-quarter 2025 ...

Shares in French pharma major Sanofi were 6% lower late Thursday after the presentation of the company’s second quarter ...

The hidradenitis suppurativa (HS) market across the seven major pharmaceutical markets (7MM) is projected to grow from $1.84 ...

UCB, Belgium’s largest drugmaker, today released financial results for first half 2025, showing total revenue in increased to ...

Japan’s Eisai and US biotech major Biogen have announced that the latest findings demonstrating the benefits of continuous ...

As Indian drug manufacturers cry foul over the surge of cheap Chinese pharmaceutical raw material imports, the Indian ...

Ipsen (Euronext: IPN) has reported second-quarter sales of 901 million euros ($980 million), up 8% from the same period a ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...